NHS England has introduced MSD UK's belzutifan as a non-surgical treatment option for von Hippel-Lindau disease. The pill, targeting three types of tumors, has shown positive results in clinical trials.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing